Evidence map›Paper›PMID 31924446›Full record

ArticleNeuron2020

Astrocyte Unfolded Protein Response Induces a Specific Reactivity State that Causes Non-Cell-Autonomous Neuronal Degeneration.

Heather L Smith, Oliver J Freeman, Adrian J Butcher, Staffan Holmqvist, Ibrahim Humoud, Tobias Schätzl, Daniel T Hughes, Nicholas C Verity, Dean P Swinden, Joseph Hayes and 4 more

Abstract read
In one paragraph

Article in Neuron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Dynamic changes in excitability and viability of sporadic andFrontiers in cell and developmental biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Heather L SmithDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Oliver J FreemanDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Adrian J ButcherDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Staffan HolmqvistWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Ibrahim HumoudDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Tobias SchätzlDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Daniel T HughesDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Nicholas C VerityMRC Toxicology Unit, Hodgkin Building, Leicester, UK.
Dean P SwindenDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Joseph HayesDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
Lis de WeerdDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK.
David H RowitchWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Robin J M FranklinWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
Giovanna R MallucciDepartment of Clinical Neurosciences and UK Dementia Research Institute at the University of Cambridge, Island Research Building, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: gm522@cam.ac.uk.

Funding

Medical Research Council G0300336Medical Research Council G0300338Medical Research Council G0700392Medical Research Council G0701476Medical Research Council G0802545Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230Medical Research Council MC_U132692719Medical Research Council MR/K008803/1Medical Research Council MR/M010503/1Medical Research Council MR/R024820/1Medical Research Council MR/S00503X/1Wellcome TrustWellcome Trust 201487/Z/16/Z
6 · The paper itself

Abstract

Recent interest in astrocyte activation states has raised the fundamental question of how these cells, normally essential for synapse and neuronal maintenance, become pathogenic. Here, we show that activation of the unfolded protein response (UPR), specifically phosphorylated protein kinase R-like endoplasmic reticulum (ER) kinase (PERK-P) signaling-a pathway that is widely dysregulated in neurodegenerative diseases-generates a distinct reactivity state in astrocytes that alters the astrocytic secretome, leading to loss of synaptogenic function in vitro. Further, we establish that the same PERK-P-dependent astrocyte reactivity state is harmful to neurons in vivo in mice with prion neurodegeneration. Critically, targeting this signaling exclusively in astrocytes during prion disease is alone sufficient to prevent neuronal loss and significantly prolongs survival. Thus, the astrocyte reactivity state resulting from UPR over-activation is a distinct pathogenic mechanism that can by itself be effectively targeted for neuroprotection.

Indexed as

AnimalsAstrocyteseIF-2 KinaseEndoplasmic Reticulum StressEnzyme InhibitorsEukaryotic Initiation Factor-2BIn Vitro TechniquesMemoryMiceNeurodegenerative DiseasesPhosphorylationPrion DiseasesProtein BiosynthesisProtein Phosphatase 1Signal TransductionSynapseseIF-2 KinaseEnzyme InhibitorsEukaryotic Initiation Factor-2BPpp1r15a protein, mouseProtein Phosphatase 1ThapsigarginTunicamycinastrocyte reactivity stateastrocytesLCN2neurodegenerationneuroprotectionPERK signallingsecretomesynapsetranslational neuroscienceunfolded protein response

Identifiers

PMID31924446
PMCPMC7054837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.